Abstract
This study shows how infection of CBA mice with L. tropica can be manipulated so as to mimic the principal features of both subclinical and self-healing cutaneous leishmaniasis in man. CBA mice were infected with graded inocula of L. tropica promastigotes. The pattern of primary infection was found to be dependent on dose of infecting organisms: mice given low dose inocula (10(2), 10(3)) developed subclinical infections; those given high dose inocula (10(4), 10(5), 10(6)) developed overt, clinical lesions. Size and duration of lesions, and antibody production were directly proportional to dose; delayed hypersensitivity responses were inversely proportional to dose. Protective immunity to challenge infection was induced by both subclinical and clinical infection; and was manifest both during and after the healing stages of primary lesions. Protective immunity was also induced by artificial immunization with sonicated promastigotes in adjuvants but was only manifest if the challenge dose was not too large. The course of challenge infections differed depending on the method of immunization, i.e. whether by infection or artificial immunization. Lymphoid cells from immune CBA mice conferred protection on recipient syngeneic CBA mice against challenge infection; serum from immune mice did not, but suspension of immune peritoneal cells in immune serum enhanced their protective capacity. The experimental induction of protective immunity by low-dose infection, without a clinical allergic response at the site of inoculation, is of importance in designing an immunoprophylactic approach to human leishmaniasis.
Full text
PDF












Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asherson G. L. The passive transfer of delayed hypersensitivity in the guinea-pig. II. The ability of passively transferred antibody to cause local inflammation and retention of antigen and the role of these phenomena in the passive transfer of delayed hypersensitivity. Immunology. 1967 Oct;13(4):441–451. [PMC free article] [PubMed] [Google Scholar]
- Bryceson A. D., Bray R. S., Wolstencroft R. A., Dumonde D. C. Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol. 1970 Sep;7(3):301–341. [PMC free article] [PubMed] [Google Scholar]
- Dumonde D. C. The role of the macrophage in delayed hypersensitivity. Br Med Bull. 1967 Jan;23(1):9–14. doi: 10.1093/oxfordjournals.bmb.a070524. [DOI] [PubMed] [Google Scholar]
- FLOCH H., CASILE M. Intradermo-réaction de Monténégro à la leishmanine. Bull Soc Pathol Exot Filiales. 1955;48(5):636–642. [PubMed] [Google Scholar]
- Kelly R. H., Wolstencroft R. A., Dumonde D. C., Balfour B. M. Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol. 1972 Jan;10(1):49–65. [PMC free article] [PubMed] [Google Scholar]
- Mauel J., Behin R. Cell-mediated and humoral immunity to protozoan infections. Transplant Rev. 1974;19(0):121–146. doi: 10.1111/j.1600-065x.1974.tb00130.x. [DOI] [PubMed] [Google Scholar]
- Preston P. M., Carter R. L., Leuchars E., Davies A. J., Dumonde D. C. Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol. 1972 Feb;10(2):337–357. [PMC free article] [PubMed] [Google Scholar]
